Biktarvy combination tablets, containing Bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate, are a fixed-dose combination antiretroviral medication. Manufactured by Gilead Sciences, these tablets are used as a complete regimen for the treatment of human immunodeficiency virus (HIV-1) infection in adults and children weighing at least 30 pounds. The medication is provided as 1 tablet with a YJ code of 6250117F1020.
Biktarvy combination tablets
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More from this manufacturer
